FAKTOR-OPTIONSSCHEIN - ORION B | Market Closed - Börse Stuttgart 20:06:25 31/05/2024 BST | ||
| 3.58 EUR | -11.82% |
|
| 1 month | -30.62% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ORION OYJ
Latest news about ORION OYJ
More news
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 3.58 | -11.82% |
| 30/05/24 | 4.06 | -4.69% |
| 29/05/24 | 4.26 | +13.00% |
| 28/05/24 | 3.77 | +4.72% |
| 27/05/24 | 3.6 | -4.76% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 08:06 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | ORION OYJ |
| Issuer | Morgan Stanley |
| WKN | MG2WH8 |
| ISIN | DE000MG2WH83 |
| Date issued | 24/04/2024 |
| Strike | 43.13 € |
| Maturity | Unlimited |
| Parity | 1.55 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.66 € |
|---|---|
| Lowest since issue | 3.5 € |
| Spread | 0.04 € |
| Spread % | 1.14% |
Company Profile
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows:
- generic, OTC and biosimilar drugs (43.4%);
- patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments;
- animal health products (8.7%);
- pharmaceutical ingredients and outsourcing services (6.2%).
Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%).
Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).
Sector
-
Consensus: Orion Oyj
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
37.48
EUR
Average target price
39
EUR
Spread / Average Target
+4.06%
- Stock Market
- Certificates
- Certificat
